Cargando…
A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors
Proton pump inhibitors (PPIs) are known as a class of pharmaceutical agents that target H(+)/K(+)-ATPase, which is located in gastric parietal cells. PPIs are widely used in the treatment of gastric acid-related diseases including peptic ulcer disease, erosive esophagitis and gastroesophageal reflux...
Autores principales: | Yu, Li-Yuan, Sun, Lu-Ning, Zhang, Xue-Hui, Li, Yue-Qi, Yu, Lei, Yuan, Zi-Qing-Yun, Meng, Ling, Zhang, Hong-Wen, Wang, Yong-Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5427147/ https://www.ncbi.nlm.nih.gov/pubmed/28429247 http://dx.doi.org/10.1007/s12325-017-0532-9 |
Ejemplares similares
-
Analysis of the Effect of Proton-Pump Inhibitors on the Course of COVID-19
por: Zhang, Xiao-Yu, et al.
Publicado: (2021) -
Proton Pump Inhibitors and the Risk of Adverse Cardiac Events
por: Juurlink, David N., et al.
Publicado: (2013) -
Adverse Effects of Proton Pump Inhibitors—Evidence and Plausibility
por: Fossmark, Reidar, et al.
Publicado: (2019) -
Adverse Effects Associated with Proton Pump Inhibitor Use
por: Yibirin, Marcel, et al.
Publicado: (2021) -
The Impact of Plasma Protein Binding Characteristics and Unbound Concentration of Voriconazole on Its Adverse Drug Reactions
por: Yuan, Zi-Qing-Yun, et al.
Publicado: (2020)